Aurobindo Pharma Limited vs Dr. Reddy's Laboratories Limited

A side-by-side comparison of Aurobindo Pharma Limited (AUROPHARMA) and Dr. Reddy's Laboratories Limited (DRREDDY) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Dr. Reddy's Laboratories Limited leads AUROPHARMA vs DRREDDY on 11 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability13
  • Growth11
  • Size & financial health04
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

DRREDDY takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

27.63
P/E ratio
24.46
2.53
P/B ratio
2.50
0.24%
Dividend yield
0.70%
₹60.34
EPS
₹50.41

Profitability

DRREDDY takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

9.25%
Return on equity
11.07%
11.96%
Return on capital
12.64%
20.34%
EBITDA margin
19.15%
10.41%
Net margin
12.34%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.63%
Revenue CAGR (3Y)
10.96%
22.03%
Profit CAGR (3Y)
-2.66%

Size & financial health

DRREDDY takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹95,513 Cr
Market cap
₹1.03L Cr
₹33,653 Cr
Revenue
₹33,700 Cr
₹3,503 Cr
Net profit
₹4,158 Cr
0.21
Debt / equity
0.20
Aurobindo Pharma Limited
  • + []
  • − ["The company has delivered a poor sales growth of 6.3% over past five years.", "The company has delivered a poor profit growth of -8.1% over past five years."]
Dr. Reddy's Laboratories Limited
  • + ["Company has delivered good profit growth of 16.3% CAGR over last 5 years"]
  • − []
Aurobindo Pharma Limited full analysis Dr. Reddy's Laboratories Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.